130 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
& Young LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2024.
To approve an amendment … Recommendation
PROPOSAL NO. 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Fees Paid to the Independent Registered Public
S-8
EX-23.1
ATHA
Athira Pharma Inc
22 Feb 24
Registration of securities for employees
4:34pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
S-8
ATHA
Athira Pharma Inc
22 Feb 24
Registration of securities for employees
4:34pm
Corporation
Consent of Independent Registered Public Accounting Firm
Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (contained
8-K
EX-10.1
pmljq d30
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
560yhjy5kc 5ur
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-10.1
7x3svfz7jd795i8my
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
rhkw2b
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
EX-99.1
4skzoxt9vp70p7
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
EX-99.1
3n7e ffgaoz17pln80
9 Nov 23
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-99.1
5m0ev6 a8e56pxya
10 Aug 23
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-10.3
6aa2ax5xhnqt
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
918w4
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am